NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/22/2025
Back to search
Official data from USPTO
VIANAUTIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
VIANAUTIS
ST13
US500000098516669Class
1, 5, 42
Filing
98516669
Registration
7765940
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
04/23/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
04/24/2024
Registration date
04/22/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/22/2025
Last transaction
04/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Cambridge, GB
Examiner
SPARROW,MARY
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
VIANAUTIS BIO LIMITED
Representatives
Ben Natter Haug Partners, LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in science; chemicals for encapsulatingmicroencapsulating and decapsulating other chemicals; chemicals for the protectiondeliverytransport and triggered or controlled release of other chemicals; chemicals for encapsulatingmicroencapsulating and decapsulating biologically active ingredients including enzymes and cells.
Class 5
Pharmaceutical preparations; reagentsdiagnosticsprophylactics and therapeutic preparations for use in conditions of the central and peripheral nervous systemsdiseases of the lungkidneyliver or any peripheral organsoncology; vaccines; therapeutic preparations for use in treating diseases of the central and peripheral nervous systemsdiseases of lungkidneyliver or other organscancer in medical and veterinary patients; targeted preparations for treating diseases of the central and peripheral nervous systemsdiseases of lungkidneyliver or other organscancer; medical and veterinary preparations for use in central and peripheral nervous system diseasesdiseases of the lungkidneyliver and other organscancer; medical and veterinary preparations for the delivery of compounds to the brain; medical and veterinary preparations for crossing the blood-brain barrier and other biological barriers; medical and veterinary preparations for delivering reagentsdiagnosticsprophylactics and therapeutics across the blood-brain barrier and other biological barriers.
Class 42
Scientific and technological servicesscientific researchanalysistesting and development in the field of delivering therapeuticsdrug delivery technologies and medicines and research and design relating thereto; industrial analysis and research services in the field of therapeuticsdrug delivery technologies and medicines; medical and veterinary research services; scientific research in the development of new therapies and new methods for delivering therapies; scientific research into nanoparticles; scientific research into encapsulationmicroencapsulation and de-capsulation of reagentsdiagnosticsprophylactics and therapeutics; scientific research into crossing the blood brain barrier and other biological barriers; scientific research into nano-engineering for intracellular delivery; consultancy relating to all the aforesaid services.
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/22/2025
PUBO
PUBLISHED FOR OPPOSITION
03/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/26/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/07/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/15/2024
GNRT
NON-FINAL ACTION E-MAILED
11/15/2024
CNRT
NON-FINAL ACTION WRITTEN
11/15/2024
DOCK
ASSIGNED TO EXAMINER
11/07/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/13/2024
NWAP
NEW APPLICATION ENTERED
04/24/2024
Continuous trademark protection
Get notified about every new filing that threatens VIANAUTIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.